FDA okays Moderna, J&J COVID jab boosters, plus ‘mix and match’The FDA has authorised booster shots with Moderna and Johnson & Johnson’s COVID-19 vaccines, a month after giving Share XFDA okays Moderna, J&J COVID jab boosters, plus ‘mix and match’https://pharmaphorum.com/news/fda-okays-moderna-jj-covid-jab-boosters-plus-mix-and-match/
Biogen, Sage prep 2022 filing for depression drug zuranoloneThe renaissance of Biogen and Sage Therapeutics antidepressant zuranolone continues, with the companies indicating they now plan to Share XBiogen, Sage prep 2022 filing for depression drug zuranolonehttps://pharmaphorum.com/news/biogen-sage-prep-2022-filing-for-depression-drug-zuranolone/
Omeros seeks urgent FDA meeting after it rejects key drugShares in Omeros plummeted yesterday after the FDA rejected approval of its narsoplimab drug for a rare and Share XOmeros seeks urgent FDA meeting after it rejects key drughttps://pharmaphorum.com/news/omeros-seeks-urgent-fda-meeting-after-it-rejects-key-drug/
FDA panel backs booster shot for J&J COVID-19 vaccineAn FDA advisory committee voted unanimously in favour of a booster dose of Johnson & Johnson’s one-shot COVID-19 Share XFDA panel backs booster shot for J&J COVID-19 vaccinehttps://pharmaphorum.com/news/fda-panel-backs-booster-shot-for-jj-covid-19-vaccine/
Califf re-joining FDA would be positive for industry; analystWith rumours growing that that ex-FDA head Robert Califf looks set to receive President Joe Biden’s nomination to Share XCaliff re-joining FDA would be positive for industry; analysthttps://pharmaphorum.com/news/califf-re-joining-fda-would-be-positive-for-industry-analyst/
Flash FDA approval sends ChemoCentryx spiralling upwardsChemoCentryx has claimed FDA approval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active Share XFlash FDA approval sends ChemoCentryx spiralling upwardshttps://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/
FDA panel backs Takeda’s CMV drug for transplant patientsTakeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ Share XFDA panel backs Takeda’s CMV drug for transplant patientshttps://pharmaphorum.com/news/fda-panel-backs-takedas-cmv-drug-for-transplant-patients/
J&J joins COVID-19 booster shot drive, filing with FDAJohnson & Johnson’s COVID-19 vaccine has been a minor player in the US vaccination drive so far, but Share XJ&J joins COVID-19 booster shot drive, filing with FDAhttps://pharmaphorum.com/news/jj-joins-covid-19-booster-shot-drive-filing-with-fda/
Enhertu nabs speedy FDA review for earlier use in breast cancerHard on the heels of impressive new data for Enhertu as a second-line therapy for breast cancer, AstraZeneca Share XEnhertu nabs speedy FDA review for earlier use in breast cancerhttps://pharmaphorum.com/news/enhertu-nabs-speedy-fda-review-for-earlier-use-in-breast-cancer/
